Reply To: Cautious Investor — Market Weekly

#98707
Truman
Participant

$MRNA Moderna To Offer $2B Convertible Senior Notes

– To Offer Some Proceeds For Capped Call Transactions
– Net Proceeds For General Corporate Purposes As Well